Abstract
Paediatric Cushing’s disease (CD) is usually associated with growth retardation, but there are only few published data on skeletal maturation at diagnosis. We analysed factors contributing to skeletal maturation and final height in Asian Indian patients with paediatric CD. We conducted retrospective analysis of 48 patients (29 males; 19 females) with mean age: 14.84 years at diagnosis (range 9–19 years). A single observer using the Greulich Pyle method determined the bone age (BA) of each child. BA delay, i.e. the difference between chronological age (CA) and BA, was compared with clinical and biochemical variables. BA delay was present in 35/48 (73%) patients (mean delay 1.6 years, range 0.5–5 years) and correlated negatively with height SDS (r = −0.594, P < 0.001) and positively with CA at diagnosis (r = 0.247, P < 0.05). There was no correlation with duration of symptoms before diagnosis, basal cortisol, midnight cortisol, ACTH or percentage suppression of low dose dexamethasone suppression cortisol (LDDST). We could not demonstrate any relationship between the duration of history before diagnosis and height SDS at final height. Mean final height SDS in patients was −1.84. We found that most children with CD had delayed BA and correlated significantly with CA and height SDS at diagnosis. Early diagnosis may reduce delay in skeletal maturation and thus contribute to optimal catch-up growth.
Similar content being viewed by others
References
Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr et al (1994) Cushing’s syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 331:629–636
Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA (1995) Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing’s syndrome. Clin Endocrinol (Oxf) 43:19–28
Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F et al (2005) Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol (Oxf) 62:466–472
Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO (2000) Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 85:3262–3265
Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP (1994) Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing’s disease before and after surgical cure. J Clin Endocrinol Metab 78:131–137
Strickland AL, Underwood LE, Voina SJ, French FS, Van Wyk JJ (1972) Growth retardation in Cushing’s syndrome. Am J Dis Child 123:207–213
Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602
Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: a prospective, long term study. Eur J Endocrinol 154:109–118
Dupuis CC, Storr HL, Perry LA, Ho JT, Ahmed L, Ong KK, Dunger DB, Monson JP, Grossman AB, Besser GM, Savage MO (2007) Abnormal puberty in paediatric Cushing’s disease: relationship with adrenal androgen, sex hormone binding globulin, gonadotrophin concentrations. Clin Endocrinol (Oxf) 66(6):838–843
Koedam JA, Smink JJ, Buul-Offers SC (2002) Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Mol Cell Endocrinol 197:35–44
Lindberg MK, Vandenput L, Moverare SS, Vanderschueren D, Boonen S, Bouillon R et al (2005) Androgens and the skeleton. Minerva Endocrinol 30:15–25
Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389–425
Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S (1992) Physical and sexual growth pattern of affluent Indian children from 5 to 18 years of age. Indian Pediatr 29:1203–1282
Peters CJ, Ahmed ML, Storr HL, Davies KM, Martin LJ, Allgrove J, Grossman AB, Savage MO (2007) Factors influencing skeletal maturation at diagnosis of paediatric Cushing’s disease. Horm Res 68:231–235
Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G et al (1998) Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139:3296–3305
Unterman TG, Phillips LS (1985) Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 61:618–626
Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr (1992) Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263:E489–E492
Salt AT, Savage MO, Grant DB (1992) Growth patterns after surgery for virilising adrenocortical adenoma. Arch Dis Child 67:234–236
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Acharya, S.V., Gopal, R.A., Lila, A. et al. Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing’s disease. Pituitary 13, 355–360 (2010). https://doi.org/10.1007/s11102-010-0246-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-010-0246-3